Upexi (UPXI) Competitors $5.64 +0.43 (+8.25%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends UPXI vs. FBRX, ACXP, COCP, PULM, BLRX, PIRS, MIRA, BTAI, CYTH, and GLYCShould you be buying Upexi stock or one of its competitors? The main competitors of Upexi include Forte Biosciences (FBRX), Acurx Pharmaceuticals (ACXP), Cocrystal Pharma (COCP), Pulmatrix (PULM), BioLineRx (BLRX), Pieris Pharmaceuticals (PIRS), MIRA Pharmaceuticals (MIRA), BioXcel Therapeutics (BTAI), Cyclo Therapeutics (CYTH), and GlycoMimetics (GLYC). These companies are all part of the "pharmaceutical products" industry. Upexi vs. Forte Biosciences Acurx Pharmaceuticals Cocrystal Pharma Pulmatrix BioLineRx Pieris Pharmaceuticals MIRA Pharmaceuticals BioXcel Therapeutics Cyclo Therapeutics GlycoMimetics Upexi (NASDAQ:UPXI) and Forte Biosciences (NASDAQ:FBRX) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and community ranking. Does the MarketBeat Community prefer UPXI or FBRX? Forte Biosciences received 25 more outperform votes than Upexi when rated by MarketBeat users. Likewise, 59.57% of users gave Forte Biosciences an outperform vote while only 42.86% of users gave Upexi an outperform vote. CompanyUnderperformOutperformUpexiOutperform Votes342.86% Underperform Votes457.14% Forte BiosciencesOutperform Votes2859.57% Underperform Votes1940.43% Do insiders & institutionals believe in UPXI or FBRX? 5.7% of Upexi shares are owned by institutional investors. Comparatively, 77.6% of Forte Biosciences shares are owned by institutional investors. 38.4% of Upexi shares are owned by company insiders. Comparatively, 9.6% of Forte Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is UPXI or FBRX more profitable? Forte Biosciences has a net margin of 0.00% compared to Upexi's net margin of -28.34%. Upexi's return on equity of -54.97% beat Forte Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Upexi-28.34% -54.97% -23.24% Forte Biosciences N/A -151.43%-118.92% Which has higher earnings and valuation, UPXI or FBRX? Upexi has higher revenue and earnings than Forte Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpexi$80.68M0.07-$16.93MN/AN/AForte BiosciencesN/AN/A-$31.48M-$16.29-0.98 Do analysts recommend UPXI or FBRX? Upexi presently has a consensus target price of $25.00, suggesting a potential upside of 343.26%. Forte Biosciences has a consensus target price of $23.58, suggesting a potential upside of 47.40%. Given Upexi's higher possible upside, equities analysts clearly believe Upexi is more favorable than Forte Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Upexi 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Forte Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, UPXI or FBRX? Upexi has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Forte Biosciences has a beta of 0.04, indicating that its share price is 96% less volatile than the S&P 500. Does the media refer more to UPXI or FBRX? In the previous week, Forte Biosciences had 12 more articles in the media than Upexi. MarketBeat recorded 13 mentions for Forte Biosciences and 1 mentions for Upexi. Forte Biosciences' average media sentiment score of 0.83 beat Upexi's score of 0.00 indicating that Forte Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Upexi 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Forte Biosciences 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryForte Biosciences beats Upexi on 8 of the 15 factors compared between the two stocks. Ad StockEarnings9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now Get Upexi News Delivered to You Automatically Sign up to receive the latest news and ratings for UPXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPXI vs. The Competition Export to ExcelMetricUpexiMedicinals & botanicals IndustryBusiness SectorNASDAQ ExchangeMarket Cap$5.87M$1.26B$6.95B$8.84BDividend YieldN/AN/A2.84%4.08%P/E RatioN/A49.1629.5317.87Price / Sales0.079.56214.7485.82Price / CashN/A11.4927.3336.92Price / Book0.182.025.226.54Net Income-$16.93M-$52.95M$124.16M$226.15M7 Day Performance37.56%-1.14%7.11%3.77%1 Month Performance88.00%-1.49%17.44%4.46%1 Year Performance-70.32%2.65%34.19%27.57% Upexi Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPXIUpexi1.4335 of 5 stars$5.64+8.3%$25.00+343.3%-70.7%$5.87M$80.68M0.00130News CoverageFBRXForte Biosciences3.9775 of 5 stars$16.00+2.3%$23.58+47.4%+92,923.3%$23.39MN/A-0.985Insider TradeNews CoverageGap DownACXPAcurx Pharmaceuticals2.3954 of 5 stars$1.35+3.8%$12.00+788.9%-64.0%$22.80MN/A-1.243Gap UpCOCPCocrystal Pharma3.0786 of 5 stars$2.20+2.3%$7.00+218.2%+47.7%$22.38MN/A-1.1910PULMPulmatrix0.0694 of 5 stars$6.12+0.2%N/A+230.8%$22.34M$7.30M-2.3220BLRXBioLineRx1.9851 of 5 stars$0.28-15.2%$21.00+7,451.2%-81.7%$22.23M$4.80M-0.6240Analyst ForecastNews CoverageHigh Trading VolumePIRSPieris Pharmaceuticals1.626 of 5 stars$16.77+5.3%N/A+2.8%$22.14M$42.81M-1.39140Analyst UpgradeMIRAMIRA Pharmaceuticals1.6553 of 5 stars$1.32+4.8%$14.00+960.6%-58.7%$21.86MN/A-2.362News CoverageBTAIBioXcel Therapeutics4.5623 of 5 stars$0.51-10.5%$5.00+882.3%-86.7%$21.76M$1.38M-0.2490News CoverageGap DownHigh Trading VolumeCYTHCyclo Therapeutics2.9738 of 5 stars$0.73+4.3%$0.95+30.1%-38.7%$21.00M$870,725.00-0.819News CoverageGLYCGlycoMimetics3.461 of 5 stars$0.32flat$10.00+3,056.6%-79.2%$20.43M$10,000.000.0050Analyst ForecastGap Up Related Companies and Tools Related Companies FBRX Alternatives ACXP Alternatives COCP Alternatives PULM Alternatives BLRX Alternatives PIRS Alternatives MIRA Alternatives BTAI Alternatives CYTH Alternatives GLYC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:UPXI) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Upexi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Upexi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPXI Stock Alerts